-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Acalabrutinib Maleate in Primary CNS Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Acalabrutinib Maleate in Primary CNS Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acalabrutinib Maleate in Primary CNS Lymphoma Drug Details: Acalabrutinib...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STP-938 in Peripheral T-Cell Lymphomas (PTCL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STP-938 in Peripheral T-Cell Lymphomas (PTCL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STP-938 in Peripheral T-Cell Lymphomas (PTCL) Drug Details: STP-938...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – KAND-567 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KAND-567 in Fallopian Tube Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KAND-567 in Fallopian Tube Cancer Drug Details: KAND-567 (AZD-8797) is under...
-
Product Insights
NewPollen Allergy – Drugs In Development, 2024
Empower your strategies with our Pollen Allergy – Drugs In Development, 2024 report and make more profitable business decisions. Pollen allergy, characterized by sensitivity to the minute particles released seasonally by trees, grasses, and weeds, occurs when these pollen grains disperse through the air in their journey to fertilize plants. The particles frequently infiltrate noses, eyes, ears, and mouths, instigating the onset of allergy symptoms. Sneezing, nasal congestion, and itchy eyes are common manifestations of the immune system's response to these...
-
Product Insights
NewSeasonal Allergic Rhinitis – Drugs In Development, 2024
Empower your strategies with our Seasonal Allergic Rhinitis – Drugs In Development, 2024 report and make more profitable business decisions. Seasonal allergic rhinitis (SAR), commonly referred to as hay fever, is an inflammatory condition affecting the upper airways in response to exposure to airborne allergens, typically pollen from trees, grasses, and weeds, particularly prevalent in certain seasons. This condition manifests in sensitized individuals, giving rise to symptoms such as sneezing, nasal congestion, a runny nose, itchy or watery eyes, and fatigue....
-
Product Insights
NewInfluenza A Virus, H1N1 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H1N1 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H1N1 infection, also known as swine flu, is a new kind of flu in humans caused by a contagious influenza virus strain. H1N1 flu infects the nose, throat, and lungs. It is spread by droplets distributed by coughing or sneezing. Signs and symptoms include cough, fever, sore throat, stuffy or runny nose, body aches, headache, and fatigue. Treatment...
-
Product Insights
NewAllergic Rhinitis – Drugs In Development, 2024
Empower your strategies with our Allergic Rhinitis – Drugs In Development, 2024 report and make more profitable business decisions. Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy or runny nose, sneezing, swollen...
-
Product Insights
NewKlebsiella Infections – Drugs In Development, 2024
Empower your strategies with our Klebsiella Infections – Drugs In Development, 2024 report and make more profitable business decisions. Klebsiella infections are caused by bacteria of the genus Klebsiella, with K. pneumoniae being the most common species associated with human infections. These bacteria are part of the normal flora in the human digestive tract and respiratory system but can cause various infections, especially in individuals with weakened immune systems or underlying health conditions. Klebsiella infections can manifest in different parts of...
-
Product Insights
NewConjunctivitis – Drugs In Development, 2024
Empower your strategies with our Conjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Conjunctivitis, commonly known as "pink eye", refers to inflammation of the conjunctiva, the thin, transparent layer covering the white part of the eye and the inner surface of the eyelids. This condition can be caused by various factors, including infections, allergies, or irritants. Viral conjunctivitis is typically caused by viruses associated with the common cold; it is highly contagious and often spreads through...
-
Product Insights
NewKlebsiella pneumoniae Infections – Drugs In Development, 2024
Empower your strategies with our Klebsiella pneumoniae Infections – Drugs In Development, 2024 report and make more profitable business decisions. Klebsiella pneumoniae is a Gram-negative bacteria. A Klebsiella pneumoniae infection is caused when the organism is able to enter the lungs, and is very common in patients with underlying diseases like diabetes, chronic lung disease, and alcoholism. It is mostly a nosocomial infection that occurs in hospitalized patients with weakened immune systems. Symptoms include necrosis, inflammation, hemorrhage, chills, dizziness, high fever,...